Australia Cell Separation Market Size & Outlook, 2023-2030
Australia cell separation market, 2018-2030 (US$M)
Related Markets
Australia cell separation market highlights
- The Australia cell separation market generated a revenue of USD 194.4 million in 2023 and is expected to reach USD 512.8 million by 2030.
- The Australia market is expected to grow at a CAGR of 14.9% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cell separation market data book summary
| Market revenue in 2023 | USD 194.4 million |
| Market revenue in 2030 | USD 512.8 million |
| Growth rate | 14.9% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
| Key market players worldwide | Thermo Fisher Scientific Inc, BD, Danaher Corp, Terumo Corp, STEMCELL Technologies, Bio-Rad Laboratories Inc, Merck KGaA, Agilent Technologies Inc, Corning Inc, Akadeum Life Sciences |
Other key industry trends
- In terms of revenue, Australia accounted for 2.1% of the global cell separation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China cell separation market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,473.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Separation Market Scope
Cell Separation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia cell separation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell separation market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 65.43% in 2023. Horizon Databook has segmented the Australia cell separation market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
The availability of advanced research facilities, highly qualified researchers, and a firm but flexible regulatory framework made Australia a powerhouse of pharmaceutical and biotechnology innovation. As per the Australian Trade and Investment Commission, Australia is home to more than 470 biotechnology companies.
The presence of established biotechnology & pharmaceutical players and the significant extent of R&D activities carried out by them are expected to create high demand for cell separation solutions & systems in the country.
Furthermore, market players are increasingly adopting inorganic growth strategies to enter the Australian market, which is anticipated to support the market growth in the country. For instance, in September 2020, Sony Biotechnology selected Sysmex as its exclusive distributor of flow cytometry products in the Australian market.
Reasons to subscribe to Australia cell separation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia cell separation market databook
-
Our clientele includes a mix of cell separation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia cell separation market , including forecasts for subscribers. This country databook contains high-level insights into Australia cell separation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia cell separation market size, by product, 2018-2030 (US$M)
Australia Cell Separation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
